Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
2,139,852
-
Total 13F shares
-
583,740
-
Share change
-
+4,401
-
Total reported value
-
$1,109,616
-
Price per share
-
$1.91
-
Number of holders
-
15
-
Value change
-
+$8,428
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) as of Q2 2023
As of 30 Jun 2023,
Indaptus Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (INDP) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
583,740 shares.
The largest 10 holders included
VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, Pine Valley Investments Ltd Liability Co, Vivaldi Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, and Tower Research Capital LLC (TRC).
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.